A Form 4 filed on August 17, 2026, reports that Tracey Thomas Travis, a director of Accenture plc (NYSE:ACN), acquired 15 Class A ordinary shares through a restricted share unit grant on August 14, 2026.
Key Highlights
- Reporting person: Tracey Thomas Travis, listed as a Director of Accenture plc
- Transaction date: August 14, 2026
- Securities acquired: 15 Class A ordinary shares via transaction code A (acquisition), at a price of $0
- Grant type: Restricted Share Units granted pursuant to anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend
- Beneficial ownership following transaction: 9,829 Class A ordinary shares held directly
- Filing signed by: Allyson Retson, Attorney-in-Fact for Tracey Thomas Travis, on August 17, 2026
Accenture Director Tracey Thomas Travis RSU Anti-Dilution Grant Details
According to the Form 4 filed with the U.S. Securities and Exchange Commission, Tracey Thomas Travis, a director at Accenture plc trading on the NYSE as ACN, received 15 Class A ordinary shares on August 14, 2026. The filing identifies the transaction code as "A," indicating an acquisition, and records the price per share as $0.
The filing's footnote explains the nature of the grant: "Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend." This type of adjustment is a standard mechanism to preserve the economic value of outstanding RSU awards when a cash dividend is paid to shareholders.
Following this transaction, the filing discloses that Travis directly beneficially owns 9,829 Class A ordinary shares. No derivative securities transactions were reported in Table II of the filing. The form was filed by one reporting person and was signed by Allyson Retson as Attorney-in-Fact for Tracey Thomas Travis on August 17, 2026.
What Was Disclosed
The filing reports a single acquisition of 15 Class A ordinary shares by Accenture director Tracey Thomas Travis on August 14, 2026, at $0 per share, resulting in direct beneficial ownership of 9,829 shares. The grant was an anti-dilution RSU adjustment tied to a cash dividend payment.




Please wait processing your request...